🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical Study of ATTR-CM

RecruitingPhase 4Ages 18 Years - 80 YearsAllSecond Affiliated Hospital, Zhejiang University, …
NCT04935021 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In this study, patients with ATTR-CM or gene carriers were selected to study the diagnosis and treatment, and long-term follow-up was conducted.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients and gene carriers of ATTR-CM confirmed in the Second Affiliated Hospital of Zhejiang University School of Medicine, regardless of gender, age 18-90 years old; * Patients who have the ability to understand the test and can cooperate with investigators Exclusion Criteria: * Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors
💊

What it tests

  • ATTR-CM
📍

Where

1 site
xiaohong University PAN
Hangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy